Cargando…
Comorbidities, Health-Related Quality of Life, Health-care Utilization in Older Persons with Hemophilia—Hematology Utilization Group Study Part VII (HUGS VII)
PURPOSE: We compare the impact of hemophilia on comorbidities, joint problems, health-related quality of life (HRQoL) and health-care utilization between two age groups: 40–49 years and ≥50 years. PATIENTS AND METHODS: The HUGS VII study recruited persons with hemophilia A or B age ≥40 years. Partic...
Autores principales: | Curtis, Randall, Manco-Johnson, Marilyn, Konkle, Barbara A, Kulkarni, Roshni, Wu, Joanne, Baker, Judith R, Ullman, Megan, Tran Jr, Duc Quang, Nichol, Michael B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109905/ https://www.ncbi.nlm.nih.gov/pubmed/35585877 http://dx.doi.org/10.2147/JBM.S354526 |
Ejemplares similares
-
Newly diagnosed congenital factor VII deficiency and utilization of recombinant activated factor VII (NovoSeven(®))
por: Bartosh, Nicole S, et al.
Publicado: (2013) -
Continuous infusion of recombinant activated factor VII: a review of data in congenital hemophilia with inhibitors and congenital factor VII deficiency
por: Rajpurkar, Madhvi, et al.
Publicado: (2018) -
Situations, VII /
por: Sartre, Jean-Paul, 1905-1980
Publicado: (1965) -
QB VII
por: Uris, Leon, 1924-2003
Publicado: (1972) -
VII CLEFA
Publicado: (1975)